A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial) - Takahashi, Kenta; Ishibashi, Eri; Kubo, Toshio; Harada, Yohei; Hayashi, Hideyuki; Kano, Masayuki; Shimizu, Yasushi; Shirota, Hidekazu; Mori, Yukiko; Muto, Manabu; Ishioka, Chikashi; Dosaka-Akita, Hirotoshi; et al. (Medicine (Baltimore), 2020)
Keywords: Antibodies, Monoclonal, Humanized - therapeutic use; Antineoplastic Agents, Immunological - therapeutic use; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Humans; Japan; Multicenter Studies as Topic; Neoplasms - drug therapy; Neoplasms - genetics; Neoplasms - pathology; Receptor, ErbB-2 - genetics; Study Protocol Clinical Trial; Trastuzumab - therapeutic use; Japan